Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Gabapentin NDC 50090-2539 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This text appears to be a medical formula used to calculate estimated creatinine clearance (CLCr) in female patients based on their serum creatinine levels (in mg/dL). However, the meaning of "140 - ight" is not clear and may be a typo or an error in the scanned text.*
This is a pain study wherein participants were given either placebo or 3600 mg/day of Gabapentin. The study was conducted for 8 weeks, which includes a 4-week dose titration period and a 4-week fixed dose period. The mean pain score at baseline was 1 and the study does not provide information about the mean pain score after the intervention.*
This appears to be a table showing the mean pain score for participants in a study. The study had a baseline period and a four-week fixed dose period, during which participants received either a placebo or gabapentin at 1800 or 2400 mg/day. There is not enough information to determine the specific type of pain being studied or any other details about the study.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.